The UK’s Cancer Drugs Fund does more harm than good

A controversial fund for expensive new cancer medicines is good for big pharma but has brought real harm for patients, says health economist Karl Claxton

—> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *